Age- and concentration-dependent elimination half-life of 2,3,7,8,-tetrachlorodibenzo-p-dioxin in Seveso children

Environmental Health Perspectives

Volumn 114, Issue 10, 2006, Pages 1596-1602

  Kerger, Brent D ^a,f   Leung, Hon Wing ^b   Scott, Paul ^c   Paustenbach, Dennis J ^c   Needham, Larry L ^d   Patterson Jr , Donald G ^d   Gerthoux, Pier M ^e   Mocarelli, Paolo ^e  

^a Health Science Resource Integration   (United States)

^b ChemRisk ^*

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d DESIO HOSPITAL   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f DABT   (Italy)

Author keywords

Children; Dioxin; Elimination; Half life; Model; Pharmacokinetics

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CHILD; CHLORACNE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; FEMALE; HALF LIFE TIME; HUMAN; INFANT; LATENT PERIOD; MALE; PLASMA HALF LIFE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX; SEX DIFFERENCE; STATISTICAL ANALYSIS; TOXICOKINETICS;

ADOLESCENT; AGE FACTORS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; HUMANS; ITALY; MALE; TETRACHLORODIBENZODIOXIN;

EID: 33749445815     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8884     Document Type: Article

References (32)

1. Abraham K, Geusau A, Tosun Y, Helge H, Bauer S, Brockmoller J. 2002. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Clin Pharmacol Ther 72:163-174.
2. Agency for Toxic Substances and Disease Registry. 1998. Toxicological Profile for Chlorinated Dibenzo-p-Dioxins. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
3. Aylward LL, Brunet RC, Carrier G, Hays SM, Cushing CA, Needham LL, et al. 2005. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Exposure Anal Environ Epidemiol 15:1-15.
4. Carrier G, Brunet RC, Brodeur J. 1995a. Modeling of the toxico-kinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues. Toxicol Appl Pharmacol 131:253-266.
5. Carrier G, Brune, RC, Brodeur J. 1995b. Modeling of the toxico-kinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/ PCDFs. Toxicol Appl Pharmacol 131:267-276.
6. Deurenberg P, Weststrate JA, Seidell JC. 1991. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutrition 65:105-114.
7. Emond C, Michaelek JE, Birnbaum LS, DeVito MJ. 2004. Use of a PBPK model with dose-dependent elimination rates predicts higher peak dioxin exposure than previously estimated. Organohalogen Compounds 66:2655-2659.
8. Freund JE. 1970. Statistics, a First Course. Englewood Cliffs, NJ: Prentice-Hall, Inc., 221-225.
9. Geusau A, Schmaldienst S, Derfler K, Papke O, Abraham K. 2002. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: kinetics and trials to enhance elimination in two patients. Arch Toxicol 76:316-325
10. Galbaldi M, Perrier D. 1982. Pharmacokinetics. 2nd ed. New York:Marcel Dekker, 1-5.
11. Grassman JA, Needham LL, Masten SA, Patterson D, Portier CJ, Lucier GW, et al. 2000. Evidence of hepatic sequestration of dioxins in humans? An examination of tissue levels and CYP1A2 expression. Organohalogen Compounds 48:87-90.
12. Hu K, Bunce NJ. 1999. Metabolism of polychlorinated dibenzo-p-dioxins and related dioxin-like compounds. J Toxicol Environ Health, Part B 2:183-210.
13. International Commission for Radiological Protection. 1975. Report of the Task Group on Reference Man. New York: Pergamon Press, 352-353.
14. Iida T, Hirakawa H, Matsueda T, Hori T. 1997. Levels of PCDDs, PCDFs and coplanar PCBs in sebum and blood of Yusho patients. Fukuoka Acta Med 88:177-185
15. Kerger BD, Leung H-W, Scott P, Paustenbach DJ. 2005. An age-dependent half-life model for estimating childhood body burdens of dibenzodioxins and dibenzofurans [Abstract]. Toxicol Sci 84(S-1):53.
16. Kerger BD, Leung H-W, Scott P, Paustenbach DJ. 2006. In press. Refinements on the age-dependent half-life model for estimating child body burdens of chlorinated dibenzodioxins and dibenzofurans. Chemosphere.
17. Kerger BD, James RC. 2006. Do epidermal tissues of humans provide a substantial sink and excretion pathway for more persistent polychlorinated biphenyls and dioxins? [Abstract]. Toxicol Sci 90(1):20.
18. Kreuzer PF, Csanady Gy, Baur C, Kessler W, Papke O, Greim H, et al. 1997. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch Toxicol 71:383-400.
19. Leung HW, Kerger BD, Paustenbach DJ. 2006. Elimination half-lives of selected polychlorinated dibenzodioxins and dibenzofurans in breast-fed human infants. J Toxicol Environ Health Part A 69:1-7.
20. Leung, HW, Kerger BD, Paustenbach DJ, Ryan JJ, Masuda Y. 2005. Age- and concentration-dependent elimination half-lives of chlorinated dibenzofurans in Yusho and Yucheng patients. Organohalogen Compounds 67:1589-1592.
21. Leung HW, Poland A, Paustenbach DJ, Murray FJ, Andersen ME. 1990a. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Toxicol Appl Pharmacol 103:399-410.
22. Leung HW, Wendling JM, Orth R, Hileman F, Paustenbach DJ. 1990b. Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatic and adipose tissues. Toxicol Lett 50:275-282.
23. Matsueda T, Hirakawa H, Iida T, Nakamura M, Nagayama J. 1995. Concentration of PCDDs/PCDFs and coplanar PCBs in human skin lipids. Organohalogen Compd 26:219-222.
24. Mocarelli P, Needham L, Marocchi A, Patterson DG, Brambilla P, Gerthoux PM, et al. 1991. Serum correlation of 2,3,7,8-tetrachlorodibenzo (p)dioxin and test results from selected residents of Seveso, Italy. J Toxicol Environ Health 32:357-364.
25. Needham LL, Gerthoux PM, Patterson DG Jr, Brambilla P, Pirkle JL, Tramacere PL, et al. 1994. Half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in serum of Seveso adults: interim report. Organohalogen Compounds 21:81-85.
26. Needham LL, Gerthoux PM, Patterson DG Jr, Brambilla P, Turner WE, Beretta C, et al. 1997/1998. Serum dioxin levels in Seveso, Italy, population in 1976. Teratog Carcinog Mutagen 17:225-240.
27. Patterson DG Jr., Hampton L, Lapeza CR Jr., Belser WT, Green V, Alexander L, et al. 1987. High resolution gas chromatographic/high resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Anal Chem 59:2000-2005.
28. Paustenbach DJ, Fehling K, Scott P, Harris M, Kerger BD. 2006. Identifying soil cleanup criteria for dioxins in urban residential soils: how have 20 years of research and risk assessment experience affected the analysis? J Toxicol Environ Health Part B 9:1-59.
29. Richter RO, Kerger BD, Leung H-W, Paustenbach DJ. 2006. Implications of age-dependent half-lives of dioxins on assessment of breast milk dose and body burden [Abstract]. Toxicol Sci 90(1):117.
30. Rohde S, Moser GA, Papke O, McLachlan MS. 1999. Clearance of PCDD/Fs via the gastrointestinal tract in occupationally exposed persons. Chemosphere 38:3397-3410.
31. Schlummer M., Moser GA, McLachlan MS. 1998. Digestive tract absorption of PCDD/Fs, PCBs, and HCB in humans: mass balances and mechanistic considerations. Toxicol Appl Pharmacol 152:128-137.
32. U.S. Environmental Protection Agency. 2000. Child-Specific Exposure Factors Handbook. Washington, DC:U.S. Environmental Protection Agency